microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

(2017) Klaus-Peter Dieckmann et al.   EUROPEAN UROLOGY

Germ cell neoplasiain situ(GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy

(2016) Daniel M Berney et al.   HISTOPATHOLOGY

The present and future of serum diagnostic tests for testicular germ cell tumours

(2016) Matthew J. Murray et al.   Nature Reviews Urology

MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid

(2016) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)

(2016) Ton van Agthoven et al.   Oncotarget

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours

(2015) Matthew J Murray et al.   BRITISH JOURNAL OF CANCER

Guidelines on Testicular Cancer: 2015 Update

(2015) Peter Albers et al.   EUROPEAN UROLOGY

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer

(2015) Isabella Syring et al.   JOURNAL OF UROLOGY

International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007

(2014) B. Trabert et al.   Andrology

MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker

(2014) M. Spiekermann et al.   Andrology

Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application

(2013) Ludmila Boublikova et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Classification, epidemiology and therapies for testicular germ cell tumours

(2013) Nikhil Vasdev et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle

(2013) Ad J.M. Gillis et al.   Molecular Oncology

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

(2012) J. Beyer et al.   ANNALS OF ONCOLOGY

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

(2012) K-P Dieckmann et al.   BRITISH JOURNAL OF CANCER

Utility of serum tumor markers during surveillance for stage I seminoma

(2012) Danny Vesprini et al.   CANCER

Identification of MicroRNAs From the miR-371∼373 and miR-302 Clusters as Potential Serum Biomarkers of Malignant Germ Cell Tumors

(2010) Matthew J. Murray et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets

(2010) Roger D. Palmer et al.   CANCER RESEARCH

Serum tumor markers and their utilization in the management of germ-cell tumors in adult males

(2010) Mohamed Salem et al.   Expert Review of Anticancer Therapy

Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights

(2009) Leendert HJ Looijenga   JOURNAL OF PATHOLOGY

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

(2008) C. M. Sturgeon et al.   CLINICAL CHEMISTRY